AQR Flex 1 Series LLC - Series J100 has made a significant move by filing a new offering under SEC Regulation D. This filing is crucial for the company as it seeks to attract investments and expand its operations in the competitive investment fund landscape.
AQR Flex 1 Series LLC - Series J100, incorporated in Delaware, operates within the pooled investment fund industry. The company is based in Greenwich, Connecticut, and is managed by AQR Capital Management II, LLC. This filing is part of the company's strategy to raise capital through private offerings.
The filing, dated October 29, 2026, indicates that the company is utilizing Rule 506(b) for its private offering, which provides a “safer harbor” for such investments. It specifies a minimum investment requirement of $15 million, aimed at accredited investors. The total offering amount is indefinite, with $15 million already sold.
According to the filing, AQR Flex 1 Series LLC - Series J100 has no non-accredited investors involved in this offering, which is a common practice in private placements to ensure compliance with SEC regulations. The investment manager is entitled to receive an annual management fee based on assets under management, although specific details on the fee percentage were not disclosed.
This development may have implications for investors looking for opportunities in the hedge fund sector, as it signals AQR's intent to leverage its management expertise to attract significant capital. The involvement of AQR Capital Management, LLC as the investment manager further emphasizes the firm's commitment to maintaining high standards in fund management.
The filing does not specify what the next steps will be for AQR Flex 1 Series LLC - Series J100, but it is expected that the company will continue to engage with potential investors to fill the remaining offering amounts.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










